Genialis
PrivateLast Round
Series A
Mar 29, 2023
Total Funding Raised
$15.3M
Momentum Score
50 /100
Company Overview
Genialis is a computational precision medicine company focused on RNA biomarkers to improve patient outcomes in oncology. The company has developed ResponderID™, a machine-learning driven platform that models diseases to discover and validate biomarkers for its biopharma partners. This platform helps pharmaceutical and diagnostic companies to accelerate translational research, validate drug targets, predict patient response to therapies, and optimally position new drugs for clinical development. Genialis is trusted by biopharma partners and uses ethnographically diverse cancer data sets to inform its clinically actionable biomarkers for targeted inhibitors and immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genialis Comps
Public and private peers based on sector, stage, and business model.
Genialis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 29, 2023 | ||||
| Grant | Oct 14, 2021 | ||||
| Seed | Nov 13, 2017 |
Key People
Founding team and executive leadership
Genialis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A |
| P5 Health Ventures | Series A |
| First Star Ventures | Series A |
| Debiopharm Innovation Fund | Series A |
| Pikas | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2025
AI-powered biomarkers for pancreatic cancer in collaboration with Cleveland Clinic.
- Oct 2, 2025
Partnering with Cleveland Clinic to develop AI biomarkers for pancreatic cancer.
Genialis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genialis's valuation, stock price, and market status.
